We are at a transitional moment in how disease control efforts are structured in middle-income countries (MICs). To meet new evolving opportunities and threats in the coming decade in MICs, we cannot ...
Anita Heywood has received funding from the ARC and NHMRC. In the past five years, she has received funding from GSK for investigator-driven grant funding related to immunisation for international ...